透過您的圖書館登入
IP:52.15.189.48
  • 學位論文

我國全民健保給付制度下影響醫療代理業者選擇代理產品因素之研究—以博而美公司為例

A Study on the Influencing Factors of Choosing Products by Medical Device Agent Under the National Health Insurance Payment System in Taiwan - A Case Study of TBMS International Corporation

指導教授 : 劉立倫
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


我國的醫療器材多半仰賴代理模式,在選擇醫療器材供應商及代理產品時,除了要瞭解產品的市場需求、產品財務指標之外,現在狀況下醫療器材上市必須符合許多法規的的要求,無論是查廠登記、許可證申請或健保給付的要求等,所以多方面的考量才能選定的醫療器材順利的上市並且有好的銷售結果。 本次研究是將博而美國際股份有限公司多年的代理經驗加上相關文獻資料及法規規範等,設計成符合FAHP 的問卷格式,在邀請醫療產業負責執行代理的專家訪談後,利用 FAHP 計算出權重,在構面部分以供應商條件指標(44.56%)最為重要,其次為健保申請因素指標(17.85%)、供應商產品銷售服務指標(15.10%)、提供許可證申請指標(14.95%)及提供查廠登記(QSD)申請指標(7.81%),在準則部分以醫療產品製程品質能力(24.79%)及醫療產品研發技術能力(11.55%)最為重要。 上述構面及準則藉由決策模式的FAHP 的權重分析後,讓未來在評估新的醫療器材代理及供應商選擇時對於考慮的條件有優先順序的排序,希望這樣的研究可以減少選擇上的盲點。

並列摘要


In Taiwan, medical equipments mostly rely on the distribution model. When choosing medical equipments suppliers and distributing products, it is necessary to understand product market demand, product financial indicators, and if the medical equipment’s comply with current regulations, including Quality System Documents, license application and health insurance payment requirements. Consideration in all aspects can successfully bring selected medical equipments to the market and lead to great sales. In this research, a questionnaire that meets FAHP guidelines was designed based on TBMS International Corporation Limited’s years of distribution experience, relevant documents and regulations. After interviewing with medical industry experts, the weights were calculated according to FAHP. The most important index is Supplier Condition Index (44.56%), following by Indicators of Health Insurance Application Factors (17.85%), Vendor Product Sales Service Index (15.10%), License Application Indicator (14.95%) and Application for Quality System Documents (7.81%). As of criteria, Quality of medical products manufacturing process (24.79%) and Medical product R&D capability (11.55%) are the most critical factors. Above mentioned aspects and criteria were analyzed by FAHP weights in order to develop a prioritization for future evaluation of new medical device agents and supplier selection. It is expected that this study will help reduce any blindness in medical products selection.

參考文獻


9. 曹淑茹(2016) 台灣汽車業於綠色零組件供應商之多準則評選;中原大學
8. 陳玉美(2006):國內醫療器材進口代理商選擇產品決策過程之研究。新北市:淡江大學管理科學研究所企業經營碩士在職專班。
2. 文崇一、楊國樞(2000);訪問調查法。社會及行為科學研究法下冊。
13. 趙正敏,鄭博文(2012):從交易成本與社會交換觀點探討醫療供應商夥伴間未來關係互動之影嚮因素;商管科技季刊 2012;13(2):131-163
5. 李文成,劉書聿,鄭博文(2008):醫材供應商評選指標之初探-層級分析法之應用。醫務管理期刊 2008;9 (3):174-186。

延伸閱讀